Prostatype Genomics AB
OTC:PGABF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Prostatype Genomics AB
OTC:PGABF
|
SE |
|
B
|
Buffalo Potash Corp
OTC:BLPTF
|
CA |
|
Key Petroleum Ltd
OTC:KPHWF
|
AU |
|
A
|
Arma Services Inc
OTC:ARMV
|
US |
|
Farmers & Merchants Bancorp Inc
NASDAQ:FMAO
|
US |
|
P
|
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
|
VN |
|
Rafarma Pharmaceuticals Inc.
OTC:RAFA
|
US |
|
First Bankers Trustshares Inc
OTC:FBTT
|
US |
|
Intraco Penta Tbk PT
IDX:INTA
|
ID |
|
Van de Velde NV
OTC:VDEVF
|
BE |
|
Motorcar Parts of America Inc
NASDAQ:MPAA
|
US |
|
T
|
Thaivivat Holdings PCL
SET:TVH
|
TH |
|
E
|
Epack Durable Ltd
NSE:EPACK
|
IN |
|
C
|
Cue Biopharma Inc
F:1UC
|
US |
|
Ataa Educational Company SJSC
SAU:4292
|
SA |
|
S
|
Samurai Capital Corp
XTSX:ACL
|
CA |
Bankruptcy Probability
Prostatype Genomics AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Prostatype Genomics AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
P
|
Prostatype Genomics AB
STO:PROGEN
|
57.3m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
457.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
230.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Prostatype Genomics AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Prostatype Genomics AB has no debt.
You can find a full breakdown on its Balance Sheet.
